In this study, Gastrodia elata polysaccharide (GEP) was successfully purified from Gastrodiae Rhizoma, and its structural properties and bioactivities were investigated. GEP, which had a molecular weight of 110.09 kDa, was a homogeneous polysaccharide comprising glucose units. The specific linkage pattern primarily comprised →4)-α-D-Glcp-(1→ and a minor proportion of →3,4)-α-D-Glcp-(1→. The branched chain primarily comprised α-D-Glcp-(1→ connected to →3,4)-α-D-Glcp-(1→ at the O-4 position. In the CL4176 Caenorhabditis elegans life experiment, the median survival was 10 days in the 250 mg/L GEP, representing a 10 % extension compared with the control group. In addition, 250 mg/L GEP significantly reduced the paralysis rate and increased the movement ability of CL4176. Moreover, quantitative real-time polymerase chain reaction results indicated that, compared with the control group, the expression of β-amyloid (Aβ) mRNA was significantly decreased by 39.75 % in CL4176 treated with 250 mg/L GEP. The potential reason was that GEP increased the expression of sod3, hsp16.1, hsp16.2, gst4, gshpx and gcs1 in CL4176 by 30.26 %, 37.72 %, 43.62 %, 37 %, 47.64 % and 66.71 %, respectively. Furthermore, GEP improved the cognitive function of APP/PS1 mice by clearing Aβ and increasing the number of neurons.